Antibody-Drug Conjugates With HER2-targeting Antibodies From Synthetic Antibody Libraries Are Highly Potent Against HER2-positive Human Gastric Tumor in Xenograft Models
mAbs - United States
doi 10.1080/19420862.2018.1541370
Full Text
Open PDFAbstract
Available in full text
Date
November 8, 2018
Authors
Publisher
Informa UK Limited